Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Arrhythmias

  Free Subscription


Articles published in J Am Coll Cardiol

Retrieve available abstracts of 264 articles:
HTML format
Text format



Single Articles


    August 2018
  1. GANDJBAKHCH E, Redheuil A, Pousset F, Charron P, et al
    Clinical Diagnosis, Imaging, and Genetics of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2018;72:784-804.
    PubMed     Text format     Abstract available


  2. COOKE JP, Sukhovershin RA
    Novel Markers for Adverse Events in Atrial Fibrillation.
    J Am Coll Cardiol. 2018;72:734-737.
    PubMed     Text format    


  3. HOROWITZ JD, De Caterina R, Heresztyn T, Alexander JH, et al
    Asymmetric and Symmetric Dimethylarginine Predict Outcomes in Patients With Atrial Fibrillation: An ARISTOTLE Substudy.
    J Am Coll Cardiol. 2018;72:721-733.
    PubMed     Text format     Abstract available


  4. GUHA A, Derbala MH, Zhao Q, Wiczer TE, et al
    Ventricular Arrhythmias Following Ibrutinib Initiation for Lymphoid Malignancies.
    J Am Coll Cardiol. 2018;72:697-698.
    PubMed     Text format    


  5. ALBERT CM
    Ranolazine in Patients With Implantable Cardioverter-Defibrillators: Ready for Prime Time?
    J Am Coll Cardiol. 2018;72:646-649.
    PubMed     Text format    


    July 2018
  6. LIN YC, Chien SC, Hsieh YC, Shih CM, et al
    Effectiveness and Safety of Standard- and Low-Dose Rivaroxaban in Asians With Atrial Fibrillation.
    J Am Coll Cardiol. 2018;72:477-485.
    PubMed     Text format     Abstract available


  7. FAUCHIER L, Cinaud A, Brigadeau F, Lepillier A, et al
    Reply: Device-Related Thrombus After Percutaneous Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2018;72:474-475.
    PubMed     Text format    


  8. KEA B, Lin AL, Olshansky B, Malveau S, et al
    Stroke Prophylaxis After a New Emergency Department Diagnosis of Atrial Fibrillation.
    J Am Coll Cardiol. 2018;72:471-472.
    PubMed     Text format    


  9. RENDA G, De Caterina R
    Sex Implications in the Response to Anticoagulant Therapy in Atrial Fibrillation.
    J Am Coll Cardiol. 2018;72:283-286.
    PubMed     Text format    


  10. LAW SWY, Lau WCY, Wong ICK, Lip GYH, et al
    Sex-Based Differences in Outcomes of Oral Anticoagulation in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2018;72:271-282.
    PubMed     Text format     Abstract available


  11. KENT AP, Brueckmann M, Fraessdorf M, Connolly SJ, et al
    Concomitant Oral Anticoagulant and Nonsteroidal Anti-Inflammatory Drug Therapy in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2018;72:255-267.
    PubMed     Text format     Abstract available


  12. HEALEY JS
    Stroke Prevention in Atrial Fibrillation: What Is Real World, and What Do Real-World Data Reveal?
    J Am Coll Cardiol. 2018;72:154-155.
    PubMed     Text format    


  13. LEE CJ, Gerds TA, Carlson N, Bonde AN, et al
    Risk of Myocardial Infarction in Anticoagulated Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2018;72:17-26.
    PubMed     Text format     Abstract available


  14. LOPES RD, Rordorf R, De Ferrari GM, Leonardi S, et al
    Reply: Digoxin Use in Atrial Fibrillation: Minimizing and Refining its Use When Still Needed.
    J Am Coll Cardiol. 2018;72:125-126.
    PubMed     Text format    


    June 2018
  15. ALKHOULI M, Noseworthy PA, Rihal CS, Holmes DR Jr, et al
    Stroke Prevention in Nonvalvular Atrial Fibrillation: A Stakeholder Perspective.
    J Am Coll Cardiol. 2018;71:2790-2801.
    PubMed     Text format     Abstract available


  16. MCCONNELL MV, Turakhia MP, Harrington RA, King AC, et al
    Mobile Health Advances in Physical Activity, Fitness, and Atrial Fibrillation: Moving Hearts.
    J Am Coll Cardiol. 2018;71:2691-2701.
    PubMed     Text format     Abstract available


  17. GLOTZER TV
    The Cacophony of Silent Atrial Fibrillation.
    J Am Coll Cardiol. 2018;71:2612-2615.
    PubMed     Text format    


  18. WONG JA, Conen D, Van Gelder IC, McIntyre WF, et al
    Progression of Device-Detected Subclinical Atrial Fibrillation and the Risk of Heart Failure.
    J Am Coll Cardiol. 2018;71:2603-2611.
    PubMed     Text format     Abstract available


    May 2018
  19. MELA T
    Smartwatches in the Fight Against Atrial Fibrillation: The Little Watch That Could.
    J Am Coll Cardiol. 2018;71:2389-2391.
    PubMed     Text format    


  20. SZE E, Daubert JP
    Reply: Early Cardiac Resynchronization Therapy for Left Bundle Branch Block-Associated Cardiomyopathies.
    J Am Coll Cardiol. 2018;71:1945-1946.
    PubMed     Text format    


  21. WANG NC, Adelstein EC, Singh M, Voigt AH, et al
    Left Bundle Branch Block-Associated Cardiomyopathies and Early Cardiac Resynchronization Therapy: Conceptualizing a Tailored Approach.
    J Am Coll Cardiol. 2018;71:1943-1944.
    PubMed     Text format    


  22. CHATZIDOU S, Kontogiannis C, Tsilimigras DI, Georgiopoulos G, et al
    Propranolol Versus Metoprolol for Treatment of Electrical Storm in Patients With Implantable Cardioverter-Defibrillator.
    J Am Coll Cardiol. 2018;71:1897-1906.
    PubMed     Text format     Abstract available


    April 2018
  23. GRACE AA, Matthews GDK
    Phenotypic Landscape and Risk Management in Long QT Syndrome: Nudging Forward.
    J Am Coll Cardiol. 2018;71:1672-1675.
    PubMed     Text format    


  24. MAZZANTI A, Maragna R, Vacanti G, Monteforte N, et al
    Interplay Between Genetic Substrate, QTc Duration, and Arrhythmia Risk in Patients With Long QT Syndrome.
    J Am Coll Cardiol. 2018;71:1663-1671.
    PubMed     Text format     Abstract available


  25. FAUCHIER L, Cinaud A, Brigadeau F, Lepillier A, et al
    Device-Related Thrombosis After Percutaneous Left Atrial Appendage Occlusion for Atrial Fibrillation.
    J Am Coll Cardiol. 2018;71:1528-1536.
    PubMed     Text format     Abstract available


  26. YU L, Zhou L, Meng G, Jiang H, et al
    Reply: Optogenetic Neuromodulation of Stellate Ganglia for Patients With Ventricular Arrhythmias, Atrial Fibrillation, Angina, and Takotsubo?
    J Am Coll Cardiol. 2018;71:1496-1497.
    PubMed     Text format    


  27. MADIAS JE
    Optogenetic Neuromodulation of Stellate Ganglia for Patients With Ventricular Arrhythmias, Atrial Fibrillation, Angina, and Takotsubo?
    J Am Coll Cardiol. 2018;71:1495-1496.
    PubMed     Text format    


    March 2018
  28. PRABHU S, Kistler PM
    Reply: Beyond Pulmonary Vein Isolation During Catheter Ablation in Atrial Fibrillation and Systolic Dysfunction.
    J Am Coll Cardiol. 2018;71:1293-1294.
    PubMed     Text format    


  29. ALDAAS OM, Padwal J, Hsu JC
    Beyond Pulmonary Vein Isolation During Catheter Ablation in Atrial Fibrillation and Systolic Dysfunction.
    J Am Coll Cardiol. 2018;71:1292-1293.
    PubMed     Text format    


  30. TURAKHIA MP
    Digoxin in Atrial Fibrillation?: Leave it Out of the Medicine Cabinet.
    J Am Coll Cardiol. 2018;71:1075-1077.
    PubMed     Text format    


  31. LOPES RD, Rordorf R, De Ferrari GM, Leonardi S, et al
    Digoxin and Mortality in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2018;71:1063-1074.
    PubMed     Text format     Abstract available


  32. BUMGARNER JM, Lambert CT, Hussein AA, Cantillon DJ, et al
    Automated Atrial Fibrillation Detection Algorithm Using Smartwatch Technology.
    J Am Coll Cardiol. 2018 Mar 7. pii: S0735-1097(18)33486.
    PubMed     Text format     Abstract available


  33. KING JB, Marrouche N
    Reply: What Is the Biological Relationship Between Left Atrial Fibrosis and Stroke in Atrial Fibrillation?
    J Am Coll Cardiol. 2018;71:1054-1056.
    PubMed     Text format    


  34. REN JF, Callans DJ, Marchlinski FE
    What Is the Biological Relationship Between Left Atrial Fibrosis and Stroke in Atrial Fibrillation?
    J Am Coll Cardiol. 2018;71:1053-1054.
    PubMed     Text format    


    February 2018
  35. VERMA A, Bhatt DL, Verma S
    Long-Term Outcomes of Post-Operative Atrial Fibrillation: Guilty as Charged.
    J Am Coll Cardiol. 2018;71:749-751.
    PubMed     Text format    


  36. KOSMIDOU I, Chen S, Kappetein AP, Serruys PW, et al
    New-Onset Atrial Fibrillation After PCI or CABG for Left Main Disease: The EXCEL Trial.
    J Am Coll Cardiol. 2018;71:739-748.
    PubMed     Text format     Abstract available


  37. FERREIRA JP, Girerd N, Gregson J, Latar I, et al
    Stroke Risk in Patients With Reduced Ejection Fraction After Myocardial Infarction Without Atrial Fibrillation.
    J Am Coll Cardiol. 2018;71:727-735.
    PubMed     Text format     Abstract available


    January 2018
  38. LINDE C, Braunschweig F
    Cardiomyopathy and Left Bundle Branch Block: A Farewell to Drugs?
    J Am Coll Cardiol. 2018;71:318-320.
    PubMed     Text format    


  39. SZE E, Samad Z, Dunning A, Campbell KB, et al
    Impaired Recovery of Left Ventricular Function in Patients With Cardiomyopathy and Left Bundle Branch Block.
    J Am Coll Cardiol. 2018;71:306-317.
    PubMed     Text format     Abstract available


  40. SHIN JI, Luo S, Alexander GC, Inker LA, et al
    Direct Oral Anticoagulants and Risk of Acute Kidney Injury in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2018;71:251-252.
    PubMed     Text format    


  41. GONZALEZ CORCIA MC, Sieira J, Pappaert G, de Asmundis C, et al
    Implantable Cardioverter-Defibrillators in Children and Adolescents With Brugada Syndrome.
    J Am Coll Cardiol. 2018;71:148-157.
    PubMed     Text format     Abstract available


  42. GAGE BF
    Stroke Prediction Rules in Atrial Fibrillation.
    J Am Coll Cardiol. 2018;71:133-134.
    PubMed     Text format    


  43. CHAO TF, Lip GYH, Liu CJ, Lin YJ, et al
    Relationship of Aging and Incident Comorbidities to Stroke Risk in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2018;71:122-132.
    PubMed     Text format     Abstract available


    December 2017
  44. KABIR RA, Doytchinova A, Liu X, Adams D, et al
    Crescendo Skin Sympathetic Nerve Activity and Ventricular Arrhythmia.
    J Am Coll Cardiol. 2017;70:3201-3202.
    PubMed     Text format    


  45. BRUGADA P
    Short QT Syndrome and Hydroquinidine: Rare Diseases and Unavailable Drugs.
    J Am Coll Cardiol. 2017;70:3016-3017.
    PubMed     Text format    


  46. MAZZANTI A, Maragna R, Vacanti G, Kostopoulou A, et al
    Hydroquinidine Prevents Life-Threatening Arrhythmic Events in Patients With Short QT Syndrome.
    J Am Coll Cardiol. 2017;70:3010-3015.
    PubMed     Text format     Abstract available


  47. REDDY VY, Doshi SK, Kar S, Gibson DN, et al
    5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials.
    J Am Coll Cardiol. 2017;70:2964-2975.
    PubMed     Text format     Abstract available


  48. KHAIRY P
    Reply: Atrial Fibrillation: The Next Epidemic for Patients With Congenital Heart Disease.
    J Am Coll Cardiol. 2017;70:2950-2951.
    PubMed     Text format    


  49. TEUWEN CP, de Groot NMS
    Atrial Fibrillation: The Next Epidemic for Patients With Congenital Heart Disease.
    J Am Coll Cardiol. 2017;70:2949-2950.
    PubMed     Text format    


  50. SANDERS P, Elliott AD, Linz D
    Upstream Targets to Treat Atrial Fibrillation.
    J Am Coll Cardiol. 2017;70:2906-2908.
    PubMed     Text format    


  51. TAKEMOTO Y, Ramirez RJ, Kaur K, Salvador-Montanes O, et al
    Eplerenone Reduces Atrial Fibrillation Burden Without Preventing Atrial Electrical Remodeling.
    J Am Coll Cardiol. 2017;70:2893-2905.
    PubMed     Text format     Abstract available


  52. DUKKIPATI SR, Koruth JS, Choudry S, Miller MA, et al
    Catheter Ablation of Ventricular Tachycardia in Structural Heart Disease: Indications, Strategies, and Outcomes-Part II.
    J Am Coll Cardiol. 2017;70:2924-2941.
    PubMed     Text format     Abstract available


  53. DUKKIPATI SR, Choudry S, Koruth JS, Miller MA, et al
    Catheter Ablation of Ventricular Tachycardia in Structurally Normal Hearts: Indications, Strategies, and Outcomes-Part I.
    J Am Coll Cardiol. 2017;70:2909-2923.
    PubMed     Text format     Abstract available


  54. YU L, Zhou L, Cao G, Po SS, et al
    Optogenetic Modulation of Cardiac Sympathetic Nerve Activity to Prevent Ventricular Arrhythmias.
    J Am Coll Cardiol. 2017;70:2778-2790.
    PubMed     Text format     Abstract available


    November 2017
  55. YAO X, Shah ND, Sangaralingham LR, Gersh BJ, et al
    Reply: NOAC Dosing in Patients With Atrial Fibrillation and Renal Dysfunction.
    J Am Coll Cardiol. 2017;70:2734-2735.
    PubMed     Text format    


  56. SHROFF GR
    NOAC Dosing in Atrial Fibrillation and Renal Dysfunction: What Measure Are You Using?
    J Am Coll Cardiol. 2017;70:2733-2734.
    PubMed     Text format    


  57. HUSSAIN A, Jain SK, Wang NC
    Improved Outcomes With Cardiology Care in Newly Diagnosed Atrial Fibrillation: Is Tachycardia-Induced Cardiomyopathy Underestimated?
    J Am Coll Cardiol. 2017;70:2730.
    PubMed     Text format    


  58. PERINO AC, Turakhia MP
    Reply: Improved Outcomes With Cardiology Care in Newly Diagnosed Atrial Fibrillation: Is Tachycardia-Induced Cardiomyopathy Underestimated?
    J Am Coll Cardiol. 2017;70:2730-2731.
    PubMed     Text format    


  59. WALSH M, Connolly SJ
    Another Dimension of Safety in the Prescription of Anticoagulants for Nonvalvular Atrial Fibrillation.
    J Am Coll Cardiol. 2017;70:2633-2635.
    PubMed     Text format    


  60. YAO X, Tangri N, Gersh BJ, Sangaralingham LR, et al
    Renal Outcomes in Anticoagulated Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2017;70:2621-2632.
    PubMed     Text format     Abstract available


  61. MOGENSEN UM, Jhund PS, Abraham WT, Desai AS, et al
    Type of Atrial Fibrillation and Outcomes in Patients With Heart Failure and Reduced Ejection Fraction.
    J Am Coll Cardiol. 2017;70:2490-2500.
    PubMed     Text format     Abstract available


    October 2017
  62. ABU-OMAR Y, Thorpe BS, Freeman C, Mills C, et al
    Recovery of Left Atrial Contractile Function After Maze Surgery in Persistent Longstanding Atrial Fibrillation.
    J Am Coll Cardiol. 2017;70:2309-2311.
    PubMed     Text format    


  63. AL-KHATIB SM, Stevenson WG, Ackerman MJ, Bryant WJ, et al
    2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the
    J Am Coll Cardiol. 2017 Oct 25. pii: S0735-1097(17)41306.
    PubMed     Text format    


  64. MILAN D
    The Com-PLEC-sity of Atrial Fibrillation Genetics.
    J Am Coll Cardiol. 2017;70:2169-2170.
    PubMed     Text format    


  65. THOROLFSDOTTIR RB, Sveinbjornsson G, Sulem P, Helgadottir A, et al
    A Missense Variant in PLEC Increases Risk of Atrial Fibrillation.
    J Am Coll Cardiol. 2017;70:2157-2168.
    PubMed     Text format     Abstract available


  66. KUSUMOTO FM, Bailey KR, Chaouki AS, Deshmukh AJ, et al
    Systematic Review for the 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical P
    J Am Coll Cardiol. 2017 Oct 24. pii: S0735-1097(17)41304.
    PubMed     Text format     Abstract available


  67. AL-KHATIB SM, Stevenson WG, Ackerman MJ, Bryant WJ, et al
    2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice
    J Am Coll Cardiol. 2017 Oct 24. pii: S0735-1097(17)41305.
    PubMed     Text format    


  68. LAVIE CJ, Pandey A, Lau DH, Alpert MA, et al
    Obesity and Atrial Fibrillation Prevalence, Pathogenesis, and Prognosis: Effects of Weight Loss and Exercise.
    J Am Coll Cardiol. 2017;70:2022-2035.
    PubMed     Text format     Abstract available


  69. HERNANDEZ-OJEDA J, Arbelo E, Borras R, Berne P, et al
    Patients With Brugada Syndrome and Implanted Cardioverter-Defibrillators: Long-Term Follow-Up.
    J Am Coll Cardiol. 2017;70:1991-2002.
    PubMed     Text format     Abstract available


  70. BARON-ESQUIVIAS G, Morillo CA, Moya-Mitjans A, Martinez-Alday J, et al
    Dual-Chamber Pacing With Closed Loop Stimulation in Recurrent Reflex Vasovagal Syncope: The SPAIN Study.
    J Am Coll Cardiol. 2017;70:1720-1728.
    PubMed     Text format     Abstract available


    September 2017
  71. PAQUETTE M, Riou Franca L, Teutsch C, Diener HC, et al
    Persistence With Dabigatran Therapy at 2 Years in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2017;70:1573-1583.
    PubMed     Text format     Abstract available


  72. NICHOL G, Sayre MR, Guerra F, Poole J, et al
    Defibrillation for Ventricular Fibrillation: A Shocking Update.
    J Am Coll Cardiol. 2017;70:1496-1509.
    PubMed     Text format     Abstract available


  73. PASTORI D, Nocella C, Farcomeni A, Bartimoccia S, et al
    Relationship of PCSK9 and Urinary Thromboxane Excretion to Cardiovascular Events in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2017;70:1455-1462.
    PubMed     Text format     Abstract available


  74. BOCCHI EA, Bestetti RB, Scanavacca MI, Cunha Neto E, et al
    Chronic Chagas Heart Disease Management: From Etiology to Cardiomyopathy Treatment.
    J Am Coll Cardiol. 2017;70:1510-1524.
    PubMed     Text format     Abstract available


  75. DEBATY G, Labarere J, Frascone RJ, Wayne MA, et al
    Long-Term Prognostic Value of Gasping During Out-of-Hospital Cardiac Arrest.
    J Am Coll Cardiol. 2017;70:1467-1476.
    PubMed     Text format     Abstract available


  76. BLOOMGARDEN ZT, Kosiborod MN, Handelsman Y
    Concomitant Diabetes and Atrial Fibrillation: No Sugarcoating the Bittersweet Reality.
    J Am Coll Cardiol. 2017;70:1336-1338.
    PubMed     Text format    


  77. ECHOUFFO-TCHEUGUI JB, Shrader P, Thomas L, Gersh BJ, et al
    Care Patterns and Outcomes in Atrial Fibrillation Patients With and Without Diabetes: ORBIT-AF Registry.
    J Am Coll Cardiol. 2017;70:1325-1335.
    PubMed     Text format     Abstract available


  78. NAZARIAN S, Zghaib T
    Is Atrial Fibrillation a Necessary Component of the Thrombogenic Atrium?
    J Am Coll Cardiol. 2017;70:1322-1324.
    PubMed     Text format    


  79. KING JB, Azadani PN, Suksaranjit P, Bress AP, et al
    Left Atrial Fibrosis and Risk of Cerebrovascular and Cardiovascular Events in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2017;70:1311-1321.
    PubMed     Text format     Abstract available


  80. ESCANDE W, Boveda S, Defaye P, Leclercq C, et al
    Outcomes in Guideline-Based Versus Off-Guideline Primary Prevention Implantable Cardioverter-Defibrillator Recipients.
    J Am Coll Cardiol. 2017;70:1302-1303.
    PubMed     Text format    


    August 2017
  81. DESIMONE CV, Graff-Radford J, El-Harasis MA, Rabinstein AA, et al
    Cerebral Amyloid Angiopathy: Diagnosis, Clinical Implications, and Management Strategies in Atrial Fibrillation.
    J Am Coll Cardiol. 2017;70:1173-1182.
    PubMed     Text format     Abstract available


  82. YANNOPOULOS D, Bartos JA, Raveendran G, Conterato M, et al
    Coronary Artery Disease in Patients With Out-of-Hospital Refractory Ventricular Fibrillation Cardiac Arrest.
    J Am Coll Cardiol. 2017;70:1109-1117.
    PubMed     Text format     Abstract available


  83. WAZNI O, Chung MK
    Catheter Ablation for Rate Controlled Atrial Fibrillation: New Horizon in Heart Failure Treatment.
    J Am Coll Cardiol. 2017 Aug 22. pii: S0735-1097(17)39348.
    PubMed     Text format    


  84. PRABHU S, Taylor AJ, Costello BT, Kaye DM, et al
    Catheter Ablation Versus Medical Rate control in Atrial Fibrillation and Systolic Dysfunction (CAMERA-MRI).
    J Am Coll Cardiol. 2017 Aug 22. pii: S0735-1097(17)39349.
    PubMed     Text format     Abstract available


  85. SILKA MJ, Bar-Cohen Y
    Prevalence of Atrial Fibrillation and Permanent Atrial Arrhythmias in Congenital Heart Disease: Sequel or Series?
    J Am Coll Cardiol. 2017;70:866-868.
    PubMed     Text format    


  86. LABOMBARDA F, Hamilton R, Shohoudi A, Aboulhosn J, et al
    Increasing Prevalence of Atrial Fibrillation and Permanent Atrial Arrhythmias in Congenital Heart Disease.
    J Am Coll Cardiol. 2017;70:857-865.
    PubMed     Text format     Abstract available


  87. POOLE JE, Prutkin JM
    Subcutaneous Implantable Cardioverter-Defibrillator Finding a Place in Sudden Cardiac Death Prevention: Emerging or Emerged?
    J Am Coll Cardiol. 2017;70:842-844.
    PubMed     Text format    


  88. BOERSMA L, Barr C, Knops R, Theuns D, et al
    Implant and Midterm Outcomes of the Subcutaneous Implantable Cardioverter-Defibrillator Registry: The EFFORTLESS Study.
    J Am Coll Cardiol. 2017;70:830-841.
    PubMed     Text format     Abstract available


  89. IWASAWA J, Koruth JS, Petru J, Dujka L, et al
    Temperature-Controlled Radiofrequency Ablation for Pulmonary Vein Isolation in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2017;70:542-553.
    PubMed     Text format     Abstract available


    July 2017
  90. SCHWARTZ PJ, Dagradi F, Castelletti S
    Evolution in Managing Long QT Syndrome: From Registries to Centers of Excellence.
    J Am Coll Cardiol. 2017;70:463-465.
    PubMed     Text format    


  91. ROHATGI RK, Sugrue A, Bos JM, Cannon BC, et al
    Contemporary Outcomes in Patients With Long QT Syndrome.
    J Am Coll Cardiol. 2017;70:453-462.
    PubMed     Text format     Abstract available


  92. SEKI A, Ishikawa T, Daumy X, Mishima H, et al
    Progressive Atrial Conduction Defects Associated With Bone Malformation Caused by a Connexin-45 Mutation.
    J Am Coll Cardiol. 2017;70:358-370.
    PubMed     Text format     Abstract available


  93. WHANG W
    Opportunities to Improve Outcomes in Atrial Fibrillation: Provider Specialty and Beyond.
    J Am Coll Cardiol. 2017;70:87-88.
    PubMed     Text format    


  94. PERINO AC, Fan J, Schmitt SK, Askari M, et al
    Treating Specialty and Outcomes in Newly Diagnosed Atrial Fibrillation: From the TREAT-AF Study.
    J Am Coll Cardiol. 2017;70:78-86.
    PubMed     Text format     Abstract available


    June 2017
  95. MILLER MA, Palaniswamy C, Dukkipati SR, Balulad S, et al
    Subcutaneous Implantable Cardioverter-Defibrillator Implantation Without Defibrillation Testing.
    J Am Coll Cardiol. 2017;69:3118-3119.
    PubMed     Text format    


  96. VASEGHI M, Barwad P, Malavassi Corrales FJ, Tandri H, et al
    Cardiac Sympathetic Denervation for Refractory Ventricular Arrhythmias.
    J Am Coll Cardiol. 2017;69:3070-3080.
    PubMed     Text format     Abstract available


  97. VIJAYARAMAN P, Bordachar P, Ellenbogen KA
    The Continued Search for Physiological Pacing: Where Are We Now?
    J Am Coll Cardiol. 2017;69:3099-3114.
    PubMed     Text format     Abstract available


  98. HALPERIN JL
    Preventing Myocardial Infarction in Patients With Atrial Fibrillation: Another Piece of the Puzzle.
    J Am Coll Cardiol. 2017;69:2910-2912.
    PubMed     Text format    


  99. LEE CJ, Pallisgaard JL, Olesen JB, Carlson N, et al
    Antithrombotic Therapy and First Myocardial Infarction in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2017;69:2901-2909.
    PubMed     Text format     Abstract available


  100. FILIPPATOS G, Farmakis D
    How to Use Beta-Blockers in Heart Failure With Reduced Ejection Fraction and Atrial Fibrillation.
    J Am Coll Cardiol. 2017;69:2897-2900.
    PubMed     Text format    


  101. YAO X, Shah ND, Sangaralingham LR, Gersh BJ, et al
    Non-Vitamin K Antagonist Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Renal Dysfunction.
    J Am Coll Cardiol. 2017;69:2779-2790.
    PubMed     Text format     Abstract available


    May 2017
  102. SOLOMON SD, Chatterjee NA
    Who Benefits From Implantable Cardioverter-Defibrillators?: Integrating Absolute, Proportional, and Competing Risk.
    J Am Coll Cardiol. 2017;69:2619-2621.
    PubMed     Text format    


  103. BILCHICK KC, Wang Y, Cheng A, Curtis JP, et al
    Seattle Heart Failure and Proportional Risk Models Predict Benefit From Implantable Cardioverter-Defibrillators.
    J Am Coll Cardiol. 2017;69:2606-2618.
    PubMed     Text format     Abstract available


  104. O'KEEFE JH, DiNicolantonio JJ
    Alcohol and Atrial Fibrillation: Mitigating the Risk.
    J Am Coll Cardiol. 2017;69:2578.
    PubMed     Text format    


  105. NATTEL S
    Atrial Fibrillation and Body Composition: Is it Fat or Lean That Ultimately Determines the Risk?
    J Am Coll Cardiol. 2017;69:2498-2501.
    PubMed     Text format    


  106. FENGER-GRON M, Overvad K, Tjonneland A, Frost L, et al
    Lean Body Mass Is the Predominant Anthropometric Risk Factor for Atrial Fibrillation.
    J Am Coll Cardiol. 2017;69:2488-2497.
    PubMed     Text format     Abstract available


  107. PETERSON ED, Pokorney SD
    New Treatment Options Fail to Close the Anticoagulation Gap in Atrial Fibrillation.
    J Am Coll Cardiol. 2017;69:2485-2487.
    PubMed     Text format    


  108. MARZEC LN, Wang J, Shah ND, Chan PS, et al
    Influence of Direct Oral Anticoagulants on Rates of Oral Anticoagulation for Atrial Fibrillation.
    J Am Coll Cardiol. 2017;69:2475-2484.
    PubMed     Text format     Abstract available


  109. DORKS M, Jobski K, Herget-Rosenthal S, Hoffmann F, et al
    Mortality and Acute Kidney Injury in Asians With Atrial Fibrillation Treated With Dabigatran or Warfarin.
    J Am Coll Cardiol. 2017;69:2471.
    PubMed     Text format    


  110. CHAN YH, Kuo CT
    Reply: Mortality and Acute Kidney Injury in Asians With Atrial Fibrillation Treated With Dabigatran or Warfarin.
    J Am Coll Cardiol. 2017;69:2471-2472.
    PubMed     Text format    


  111. MUELLER KAL, Heinzmann D, Klingel K, Fallier-Becker P, et al
    Histopathological and Immunological Characteristics of Tachycardia-Induced Cardiomyopathy.
    J Am Coll Cardiol. 2017;69:2160-2172.
    PubMed     Text format     Abstract available


  112. SANTANGELI P, Frankel DS, Tung R, Vaseghi M, et al
    Early Mortality After Catheter Ablation of Ventricular Tachycardia in Patients With Structural Heart Disease.
    J Am Coll Cardiol. 2017;69:2105-2115.
    PubMed     Text format     Abstract available


    April 2017
  113. HUCKER WJ, Hanley A, Ellinor PT
    Improving Atrial Fibrillation Therapy: Is There a Gene for That?
    J Am Coll Cardiol. 2017;69:2088-2095.
    PubMed     Text format     Abstract available


  114. SUNDARAM V, Sahadevan J, Waldo AL, Stukenborg GJ, et al
    Implantable Cardioverter-Defibrillators With Versus Without Resynchronization Therapy in Patients With a QRS Duration >180 ms.
    J Am Coll Cardiol. 2017;69:2026-2036.
    PubMed     Text format     Abstract available


  115. HOBBELT AH, Spronk HM, Crijns HJ, Ten Cate H, et al
    Prethrombotic State in Young Very Low-Risk Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2017;69:1990-1992.
    PubMed     Text format    


  116. DU X, Dong J, Ma C
    Is Atrial Fibrillation a Preventable Disease?
    J Am Coll Cardiol. 2017;69:1968-1982.
    PubMed     Text format     Abstract available


  117. LORBERBAUM T, Tatonetti NP
    Reply: Combination Therapy With Ceftriaxone and Lansoprazole, Acquired Long QT Syndrome and Torsades de Pointes Risk.
    J Am Coll Cardiol. 2017;69:1877-1878.
    PubMed     Text format    


  118. LAZZERINI PE, Bertolozzi I, Rossi M, Capecchi PL, et al
    Combination Therapy With Ceftriaxone and Lansoprazole, Acquired Long QT Syndrome, and Torsades de Pointes Risk.
    J Am Coll Cardiol. 2017;69:1876-1877.
    PubMed     Text format    


  119. SANTANGELI P, Rame JE, Birati EY, Marchlinski FE, et al
    Management of Ventricular Arrhythmias in Patients With Advanced Heart Failure.
    J Am Coll Cardiol. 2017;69:1842-1860.
    PubMed     Text format     Abstract available


  120. DRIESSEN AH, Berger WR, Chan Pin Yin DR, Piersma FR, et al
    Electrophysiologically Guided Thoracoscopic Surgery for Advanced Atrial Fibrillation: 5-Year Follow-up.
    J Am Coll Cardiol. 2017;69:1753-1754.
    PubMed     Text format    


  121. FLETCHER G
    Atrial Fibrillation: A Threat to the Failing Heart?
    J Am Coll Cardiol. 2017;69:1692-1693.
    PubMed     Text format    


  122. LUO N, Merrill P, Parikh KS, Whellan DJ, et al
    Exercise Training in Patients With Chronic Heart Failure and Atrial Fibrillation.
    J Am Coll Cardiol. 2017;69:1683-1691.
    PubMed     Text format     Abstract available


    March 2017
  123. BREITHARDT G
    NOACs for Stroke Prevention in Atrial Fibrillation With Valve Disease: Filling the Gaps.
    J Am Coll Cardiol. 2017;69:1383-1385.
    PubMed     Text format    


  124. RENDA G, Ricci F, Giugliano RP, De Caterina R, et al
    Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Disease.
    J Am Coll Cardiol. 2017;69:1363-1371.
    PubMed     Text format     Abstract available


  125. DE CATERINA R, Renda G, Carnicelli AP, Nordio F, et al
    Valvular Heart Disease Patients on Edoxaban or Warfarin in the ENGAGE AF-TIMI 48 Trial.
    J Am Coll Cardiol. 2017;69:1372-1382.
    PubMed     Text format     Abstract available


  126. LIM HS, Hocini M, Dubois R, Denis A, et al
    Complexity and Distribution of Drivers in Relation to Duration of Persistent Atrial Fibrillation.
    J Am Coll Cardiol. 2017;69:1257-1269.
    PubMed     Text format     Abstract available


  127. MILLER JM, Kalra V, Das MK, Jain R, et al
    Clinical Benefit of Ablating Localized Sources for Human Atrial Fibrillation: The Indiana University FIRM Registry.
    J Am Coll Cardiol. 2017;69:1247-1256.
    PubMed     Text format     Abstract available


  128. ARBUSTINI E, Favalli V, Narula N, Serio A, et al
    Reply: A Distinct Cardiomyopathy: HCN4 Syndrome Comprising Myocardial Noncompaction, Bradycardia, Mitral Valve Defects, and Aortic Dilation.
    J Am Coll Cardiol. 2017;69:1210-1211.
    PubMed     Text format    


  129. SCHWEIZER PA, Koenen M, Katus HA, Thomas D, et al
    A Distinct Cardiomyopathy: HCN4 Syndrome Comprising Myocardial Noncompaction, Bradycardia, Mitral Valve Defects, and Aortic Dilation.
    J Am Coll Cardiol. 2017;69:1209-1210.
    PubMed     Text format    


    February 2017
  130. SHARMA S, Drezner JA, Baggish A, Papadakis M, et al
    International Recommendations for Electrocardiographic Interpretation in Athletes.
    J Am Coll Cardiol. 2017;69:1057-1075.
    PubMed     Text format     Abstract available


  131. KABRA R, Girotra S, Vaughan Sarrazin M
    Reply: Race and Stroke Risk in Atrial Fibrillation: The Limitations of a Social Construct.
    J Am Coll Cardiol. 2017;69:907-908.
    PubMed     Text format    


  132. JOHNSON AE, Magnani JW
    Race and Stroke Risk in Atrial Fibrillation: The Limitations of a Social Construct.
    J Am Coll Cardiol. 2017;69:906-907.
    PubMed     Text format    


  133. DEEDWANIA P, Acharya T
    Anticoagulation in Atrial Fibrillation: Is the Paradigm Really Shifting?
    J Am Coll Cardiol. 2017;69:786-788.
    PubMed     Text format    


  134. HUISMAN MV, Rothman KJ, Paquette M, Teutsch C, et al
    The Changing Landscape for Stroke Prevention in AF: Findings From the GLORIA-AF Registry Phase 2.
    J Am Coll Cardiol. 2017;69:777-785.
    PubMed     Text format     Abstract available


  135. BONDE AN, Lip GY, Kamper AL, Staerk L, et al
    Effect of Reduced Renal Function on Time in Therapeutic Range Among Anticoagulated Atrial Fibrillation Patients.
    J Am Coll Cardiol. 2017;69:752-753.
    PubMed     Text format    


  136. VADUGANATHAN M, Patel RB, Michel A, Shah SJ, et al
    Mode of Death in Heart Failure With Preserved Ejection Fraction.
    J Am Coll Cardiol. 2017;69:556-569.
    PubMed     Text format     Abstract available


  137. VENLET J, Piers SR, Jongbloed JD, Androulakis AF, et al
    Isolated Subepicardial Right Ventricular Outflow Tract Scar in Athletes With Ventricular Tachycardia.
    J Am Coll Cardiol. 2017;69:497-507.
    PubMed     Text format     Abstract available


    January 2017
  138. PICCINI JP, Granger CB
    Insulin Therapy and Stroke Risk in Patients With Diabetes and Atrial Fibrillation: Guilty by Association?
    J Am Coll Cardiol. 2017;69:420-422.
    PubMed     Text format    


  139. PATTI G, Lucerna M, Cavallari I, Ricottini E, et al
    Insulin-Requiring Versus Noninsulin-Requiring Diabetes and Thromboembolic Risk in Patients With Atrial Fibrillation: PREFER in AF.
    J Am Coll Cardiol. 2017;69:409-419.
    PubMed     Text format     Abstract available


  140. VAL-BLASCO A, Piedras MJ, Ruiz-Hurtado G, Suarez N, et al
    Role of NOD1 in Heart Failure Progression via Regulation of Ca2+ Handling.
    J Am Coll Cardiol. 2017;69:423-433.
    PubMed     Text format     Abstract available


  141. VAUGHAN SARRAZIN MS, Jones M, Mazur A, Cram P, et al
    Cost of Hospital Admissions in Medicare Patients With Atrial Fibrillation Taking Warfarin, Dabigatran, or Rivaroxaban.
    J Am Coll Cardiol. 2017;69:360-362.
    PubMed     Text format    


  142. HUMMEL J
    Substrate Ablation Without Pulmonary Vein Isolation: A Reasonable Proposition for Atrial Fibrillation Ablation?
    J Am Coll Cardiol. 2017;69:322-324.
    PubMed     Text format    


  143. GOLDBERGER JJ, Mitrani RD
    Autonomic Tone and Atrial Fibrillation: A Double-Edged Sword?
    J Am Coll Cardiol. 2017;69:300-302.
    PubMed     Text format    


  144. AGARWAL SK, Norby FL, Whitsel EA, Soliman EZ, et al
    Cardiac Autonomic Dysfunction and Incidence of Atrial Fibrillation: Results From 20 Years Follow-Up.
    J Am Coll Cardiol. 2017;69:291-299.
    PubMed     Text format     Abstract available


  145. BETZ JK, Katz DF, Peterson PN, Borne RT, et al
    Outcomes Among Older Patients Receiving Implantable Cardioverter-Defibrillators for Secondary Prevention: From the NCDR ICD Registry.
    J Am Coll Cardiol. 2017;69:265-274.
    PubMed     Text format     Abstract available


  146. SEITZ J, Bars C, Theodore G, Beurtheret S, et al
    AF Ablation Guided by Spatiotemporal Electrogram Dispersion Without Pulmonary Vein Isolation: A Wholly Patient-Tailored Approach.
    J Am Coll Cardiol. 2017;69:303-321.
    PubMed     Text format     Abstract available


  147. MADHAVAN M, Mulpuru SK, McLeod CJ, Cha YM, et al
    Advances and Future Directions in Cardiac Pacemakers: Part 2 of a 2-Part Series.
    J Am Coll Cardiol. 2017;69:211-235.
    PubMed     Text format     Abstract available


  148. MULPURU SK, Madhavan M, McLeod CJ, Cha YM, et al
    Cardiac Pacemakers: Function, Troubleshooting, and Management: Part 1 of a 2-Part Series.
    J Am Coll Cardiol. 2017;69:189-210.
    PubMed     Text format     Abstract available


  149. DOHERTY JU, Gluckman TJ, Hucker WJ, Januzzi JL Jr, et al
    2017 ACC Expert Consensus Decision Pathway for Periprocedural Management of Anticoagulation in Patients With Nonvalvular Atrial Fibrillation: A Report of the American College of Cardiology Clinical Expert Consensus Document Task Force.
    J Am Coll Cardiol. 2017 Jan 5. pii: S0735-1097(16)37085.
    PubMed     Text format    


    December 2016
  150. VOSKOBOINIK A, Prabhu S, Ling LH, Kalman JM, et al
    Alcohol and Atrial Fibrillation: A Sobering Review.
    J Am Coll Cardiol. 2016;68:2567-2576.
    PubMed     Text format     Abstract available


  151. JAMES CA, Calkins H
    Further Progress in Predicting Life-Threatening Arrhythmias in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.
    J Am Coll Cardiol. 2016;68:2551-2553.
    PubMed     Text format    


  152. MAZZANTI A, Ng K, Faragli A, Maragna R, et al
    Arrhythmogenic Right Ventricular Cardiomyopathy: Clinical Course and Predictors of Arrhythmic Risk.
    J Am Coll Cardiol. 2016;68:2540-2550.
    PubMed     Text format     Abstract available


  153. GOMEZ-OUTES A, Lagunar-Ruiz J, Terleira-Fernandez AI, Calvo-Rojas G, et al
    Causes of Death in Anticoagulated Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2016;68:2508-2521.
    PubMed     Text format     Abstract available


  154. KALMAN JM, Nalliah CJ, Sanders P
    Surgical Weight Loss and Atrial Fibrillation: A Convenient Paradigm to Evaluate a Complex Problem.
    J Am Coll Cardiol. 2016;68:2505-2507.
    PubMed     Text format    


  155. JAMALY S, Carlsson L, Peltonen M, Jacobson P, et al
    Bariatric Surgery and the Risk of New-Onset Atrial Fibrillation in Swedish Obese Subjects.
    J Am Coll Cardiol. 2016;68:2497-2504.
    PubMed     Text format     Abstract available


  156. HSU JC, Maddox TM, Marcus GM
    Reply: Anticoagulation Treatment for Stroke Prevention in Atrial Fibrillation Is Increasing, But Further Improvements Needed.
    J Am Coll Cardiol. 2016;68:2493.
    PubMed     Text format    


  157. BROWN JD, Shewale AR, Dherange P, Talbert JC, et al
    Anticoagulation Treatment for Stroke Prevention in Atrial Fibrillation Is Increasing, But Further Improvements Needed.
    J Am Coll Cardiol. 2016;68:2492.
    PubMed     Text format    


    November 2016
  158. CHAN YH, Yeh YH, See LC, Wang CL, et al
    Acute Kidney Injury in Asians With Atrial Fibrillation Treated With Dabigatran or Warfarin.
    J Am Coll Cardiol. 2016;68:2272-2283.
    PubMed     Text format     Abstract available


  159. KOTECHA D, Lam CS, Van Veldhuisen DJ, Van Gelder IC, et al
    Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation: Vicious Twins.
    J Am Coll Cardiol. 2016;68:2217-2228.
    PubMed     Text format     Abstract available


  160. MARCHLINSKI FE, Edvardsen T
    Arrhythmogenic Right Ventricular Cardiomyopathy: Better Tools for Detecting Early Disease and Progression.
    J Am Coll Cardiol. 2016;68:2198-2200.
    PubMed     Text format    


  161. MAST TP, Teske AJ, Walmsley J, van der Heijden JF, et al
    Right Ventricular Imaging and Computer Simulation for Electromechanical Substrate Characterization in Arrhythmogenic Right Ventricular Cardiomyopathy.
    J Am Coll Cardiol. 2016;68:2185-2197.
    PubMed     Text format     Abstract available


  162. SEEGER J, Gonska B, Rodewald C, Wolfgang Rottbauer, et al
    TCT-227 Apixaban in patients with atrial fibrillation after transfemoral aortic valve implantation compared with vitamin K antagonist.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  163. FAGGIONI M, Chandrasekhar J, Aquino M, Vogel B, et al
    TCT-224 Real world use of antithrombotic regimens after percutaneous coronary intervention in patients with atrial fibrillation.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  164. DORDI R, Kosmidou I, Redfors B, Dizon J, et al
    TCT-199 Incidence, Predictors, and Outcomes of High-Grade Atrioventricular Block in Patients With STEMI Undergoing Primary PCI: The HORIZONS-AMI Trial.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  165. PATEL N, Patel N, Arora S, Badheka A, et al
    TCT-118 Sex Differences in Coronary Angiography, Percutaneous Coronary Intervention, and Outcomes During Hospitalization After Out of Hospital Cardiac Arrest with Ventricular Fibrillation or Pulseless Ventricular Tachycardia.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  166. HENRY T, Patel A, Schaer G, DeMaria A, et al
    TCT-824 Reduction in Ventricular Arrhythmias with Ixmyelocel-T: Results from the IxCell-DCM Trial.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  167. GHIRARDI G, Ferrari C, Pontone G, Trabattoni D, et al
    TCT-809 Stenting for the treatment of pulmonary vein stenosis after atrial fibrillation radiofrequency catheter ablation: initial experience with peripheral stents plus drug-coated balloons and coronary drug-eluting stents.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  168. KINDSVATER S, Squiers J, Tabachnick D, Brown DL, et al
    TCT-754 New Persistent Left Bundle Branch Block after Transcatheter Aortic Valve Replacement is Associated with High Rate of Mortality.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  169. SANNINO A, Stoler RC, Lima B, Szerlip M, et al
    TCT-648 Atrial Fibrillation in Patients Undergoing Transcatheter Aortic Valve Replacement.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  170. LEE SH, Cho JY, Joo HJ, Park JH, et al
    TCT-620 A comparison of clinical outcomes between triple antithrombotic therapy versus dual antiplatelet with left atrial appendage occlusion in patients with atrial fibrillation undergoing drug-eluting stent implantation.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  171. REDDY V, Akehurst R, Gavaghan M, Amorosi S, et al
    TCT-617 Cost Effectiveness Following Treatment Initiation of Stroke Reduction Strategies in Non-Valvular Atrial Fibrillation: Warfarin vs NOACs vs Left Atrial Appendage Closure.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  172. PARK DW, Kang SH, Choi H, Ahn JM, et al
    TCT-327 Prevalence, Management, and Outcomes of Atrial Fibrillation Among Patients Undergoing Percutaneous Coronary Intervention with Drug-eluting Stents.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  173. FRANCO LN, Sahay S, Rodes-Cabau J, Jimenez P, et al
    TCT-25 Efficacy and Safety of Left Atrial Appendage Closure Versus Medical Treatment in Atrial Fibrillation: A Network Metaanalysis From Randomized Trials.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


    October 2016
  174. REDDY VY, Gibson DN, Kar S, O'Neill W, et al
    Post-FDA Approval, Initial US Clinical Experience with Watchman Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation.
    J Am Coll Cardiol. 2016 Oct 27. pii: S0735-1097(16)36641.
    PubMed     Text format     Abstract available


  175. GOLLOB MH
    Toward Translation of Genomic Discovery to Clinical Efficacy in Atrial Fibrillation.
    J Am Coll Cardiol. 2016;68:1895-1897.
    PubMed     Text format    


    September 2016
  176. LAU YC, Proietti M, Guiducci E, Blann AD, et al
    Atrial Fibrillation and Thromboembolism in Patients With Chronic Kidney Disease.
    J Am Coll Cardiol. 2016;68:1452-64.
    PubMed     Text format     Abstract available


  177. CHAN YH, Kuo CT, Yeh YH, Chang SH, et al
    Thromboembolic, Bleeding, and Mortality Risks of Rivaroxaban and Dabigatran in Asians With Nonvalvular Atrial Fibrillation.
    J Am Coll Cardiol. 2016;68:1389-401.
    PubMed     Text format     Abstract available


  178. GIERULA J, Paton MF, Byrom R, Cubbon RM, et al
    Reply: The Paradox of Heart Failure and Atrial Fibrillation.
    J Am Coll Cardiol. 2016;68:1253.
    PubMed     Text format    


  179. CERIT L
    The Paradox of Heart Failure and Atrial Fibrillation.
    J Am Coll Cardiol. 2016;68:1252-3.
    PubMed     Text format    


  180. ESCANDE W, Marijon E, Defaye P, Piot O, et al
    Electrical Storms in Patients With Implantable Cardioverter-Defibrillators for Primary Prevention.
    J Am Coll Cardiol. 2016;68:1248-50.
    PubMed     Text format    


  181. HYLEK EM, Ko D
    Atrial Fibrillation and Fall Risk: What Are the Treatment Implications?
    J Am Coll Cardiol. 2016;68:1179-80.
    PubMed     Text format    


  182. STEFFEL J, Giugliano RP, Braunwald E, Murphy SA, et al
    Edoxaban Versus Warfarin in Atrial Fibrillation Patients at Risk of Falling: ENGAGE AF-TIMI 48 Analysis.
    J Am Coll Cardiol. 2016;68:1169-78.
    PubMed     Text format     Abstract available


  183. MICHAUD GF, Kumar S
    Surgical Ganglionic Plexus Ablation in Atrial Fibrillation: Is All Hope Lost for the Plexus?
    J Am Coll Cardiol. 2016;68:1166-8.
    PubMed     Text format    


  184. DRIESSEN AH, Berger WR, Krul SP, van den Berg NW, et al
    Ganglion Plexus Ablation in Advanced Atrial Fibrillation: The AFACT Study.
    J Am Coll Cardiol. 2016;68:1155-65.
    PubMed     Text format     Abstract available


  185. TAMAYO SG, Simeone JC, Nordstrom BL, Patel MR, et al
    Risk Factors for Major Bleeding in Rivaroxaban Users With Atrial Fibrillation.
    J Am Coll Cardiol. 2016;68:1144-6.
    PubMed     Text format    


    August 2016
  186. CURTIS JP, Akar JG
    A Fresh Perspective on Atrial Fibrillation.
    J Am Coll Cardiol. 2016;68:905-7.
    PubMed     Text format    


  187. SUTTON NR, Seth M, Ruwende C, Gurm HS, et al
    Outcomes of Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2016;68:895-904.
    PubMed     Text format     Abstract available


  188. PARASHAR A, Sud K, Devgun J, Agarwal S, et al
    Feasibility of LAA Closure for Left Atrial Thrombus in Patients With Aortic Stenosis and AF.
    J Am Coll Cardiol. 2016;68:770-1.
    PubMed     Text format    


  189. OLDE NORDKAMP LR, Conte G, Rosenmoller BR, Warnaars JL, et al
    Brugada Syndrome and the Subcutaneous Implantable Cardioverter-Defibrillator.
    J Am Coll Cardiol. 2016;68:665-6.
    PubMed     Text format    


  190. GRANGER CB, Thomas KL
    Stroke Prediction in Atrial Fibrillation: Is it Black and White?
    J Am Coll Cardiol. 2016;68:471-2.
    PubMed     Text format    


  191. KABRA R, Girotra S, Vaughan Sarrazin M
    Refining Stroke Prediction in Atrial Fibrillation Patients by Addition of African-American Ethnicity to CHA2DS2-VASc Score.
    J Am Coll Cardiol. 2016;68:461-70.
    PubMed     Text format     Abstract available


    July 2016
  192. YAP SC, Ramjankhan F, Muslem R, de Jonge N, et al
    Ventricular Arrhythmias in Patients With a Continuous-Flow Left Ventricular Assist Device.
    J Am Coll Cardiol. 2016;68:323-5.
    PubMed     Text format    


  193. RAMOS R, Comas-Cufi M, Alves-Cabratosa L, Garcia-Gil M, et al
    Reply: Peripheral Artery Disease and Atrial Fibrillation: The Dangerous Combination.
    J Am Coll Cardiol. 2016;68:238.
    PubMed     Text format    


  194. KESER A, Ozbek K, Katlandur H, Ulucan S, et al
    Peripheral Artery Disease and Atrial Fibrillation: The Dangerous Combination.
    J Am Coll Cardiol. 2016;68:237-8.
    PubMed     Text format    


  195. DHRUVA SS, Redberg RF
    Sex-Specific Data for the Subcutaneous Implantable Cardioverter-Defibrillator.
    J Am Coll Cardiol. 2016;68:133.
    PubMed     Text format    


  196. DEL-CARPIO MUNOZ F, Yao X, Abraham NS, Bellolio MF, et al
    Dabigatran Versus Warfarin in Relation to Renal Function in Patients With Atrial Fibrillation.
    J Am Coll Cardiol. 2016;68:129-31.
    PubMed     Text format    


    June 2016
  197. NOSEWORTHY PA, Yao X, Shah ND, Gersh BJ, et al
    Stroke and Bleeding Risks in NOAC- and Warfarin-Treated Patients With Hypertrophic Cardiomyopathy and Atrial Fibrillation.
    J Am Coll Cardiol. 2016;67:3020-1.
    PubMed     Text format    


  198. DESHPANDE S, Wann LS
    Aspirin in Atrial Fibrillation: The Clot Thickens.
    J Am Coll Cardiol. 2016;67:2924-6.
    PubMed     Text format    


  199. HSU JC, Maddox TM, Kennedy K, Katz DF, et al
    Aspirin Instead of Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Risk for Stroke.
    J Am Coll Cardiol. 2016;67:2913-23.
    PubMed     Text format     Abstract available


  200. HEIDENREICH PA, Solis P, Estes NA 3rd, Fonarow GC, et al
    2016 ACC/AHA Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.
    J Am Coll Cardiol. 2016 Jun 24. pii: S0735-1097(16)32400.
    PubMed     Text format    


  201. HAVAKUK O, Viskin S
    Reply: Long-QT Syndrome, Brugada Syndrome, and Catecholaminergic Polymorphic Ventricular Tachycardia: A Tale of 3 Diseases : Ibutilide as a Torsade de Pointes Stress Test.
    J Am Coll Cardiol. 2016;67:2806-7.
    PubMed     Text format    


  202. PATANE S
    Long-QT Syndrome, Brugada Syndrome, and Catecholaminergic Polymorphic Ventricular Tachycardia: A Tale of 3 Diseases.
    J Am Coll Cardiol. 2016;67:2805.
    PubMed     Text format    


  203. VOGLER J, Willems S, Steven D
    Reply: Persistent Atrial Fibrillation: Time to Stop Comparing Apples With Oranges: Atrial Fibrillation: Beyond the Pulmonary Veins.
    J Am Coll Cardiol. 2016;67:2701-2.
    PubMed     Text format    


  204. SCHRICKER AA, Krummen DE, Hsu JC
    Atrial Fibrillation: Beyond the Pulmonary Veins.
    J Am Coll Cardiol. 2016;67:2700-1.
    PubMed     Text format    


  205. PROVIDENCIA R, Lambiase PD
    Persistent Atrial Fibrillation: Time to Stop Comparing Apples With Oranges.
    J Am Coll Cardiol. 2016;67:2699-700.
    PubMed     Text format    


    May 2016
  206. LIAO Z, Zhan X, Wu S, Xue Y, et al
    Reply: Cautionary Pulmonary Insufficiency in Ablation of Ventricular Arrhythmias From Pulmonary Sinus Cusps.
    J Am Coll Cardiol. 2016;67:2562.
    PubMed     Text format    


  207. REN JF, Callans DJ, Marchlinski FE
    Cautionary Pulmonary Insufficiency in Ablation of Ventricular Arrhythmias From Pulmonary Sinus Cusps.
    J Am Coll Cardiol. 2016;67:2560-2.
    PubMed     Text format    


  208. PIAZZA G, Karipineni N, Goldberg HS, Jenkins KL, et al
    Underutilization of Anticoagulation for Stroke Prevention in Atrial Fibrillation.
    J Am Coll Cardiol. 2016;67:2444-6.
    PubMed     Text format    


  209. ASHBURNER JM, Singer DE
    Reply: Recent Diabetes and Atrial Fibrillation Report Diverges From Pre-Existing Evidence.
    J Am Coll Cardiol. 2016;67:2319.
    PubMed     Text format    


  210. OVERVAD TF, Bronnum Nielsen P, Bjerregaard Larsen T
    Recent Diabetes and Atrial Fibrillation Report Diverges From Pre-Existing Evidence.
    J Am Coll Cardiol. 2016;67:2318-9.
    PubMed     Text format    


  211. VAN DEN HAM HA, Klungel OH, Singer DE, Leufkens HG, et al
    Reply: Comparing the ATRIA, CHADS2, and CHA2DS2-VASc Scores for Stroke Prediction in Atrial Fibrillation.
    J Am Coll Cardiol. 2016;67:2317-8.
    PubMed     Text format    


  212. POTPARA TS, Olesen JB
    Comparing the ATRIA, CHADS2, and CHA2DS2-VASc Scores for Stroke Prediction in Atrial Fibrillation.
    J Am Coll Cardiol. 2016;67:2316-7.
    PubMed     Text format    


  213. SINNECKER D, Dommasch M, Steger A, Berkefeld A, et al
    Expiration-Triggered Sinus Arrhythmia Predicts Outcome in Survivors of Acute Myocardial Infarction.
    J Am Coll Cardiol. 2016;67:2213-20.
    PubMed     Text format     Abstract available


  214. LIAO Z, Zhan X, Wu S, Xue Y, et al
    Reply: Our Perspective on Ventricular Arrhythmias Originating From Pulmonary Sinus Cusp.
    J Am Coll Cardiol. 2016;67:2196-7.
    PubMed     Text format    


  215. YANG Y, Liu Q, Zhou S, Xiao Y, et al
    Our Perspective on Ventricular Arrhythmias Originating From Pulmonary Sinus Cusp.
    J Am Coll Cardiol. 2016;67:2195-6.
    PubMed     Text format    


  216. SAFDER TB, Badgett RG
    Predicting Stroke in Patients With Atrial Fibrillation: An Incomplete Picture Without Considering Quality of Anticoagulation.
    J Am Coll Cardiol. 2016;67:2192-3.
    PubMed     Text format    


    April 2016
  217. TJONG FV, Brouwer TF, Kooiman KM, Smeding L, et al
    Communicating Antitachycardia Pacing-Enabled Leadless Pacemaker and Subcutaneous Implantable Defibrillator.
    J Am Coll Cardiol. 2016;67:1865-6.
    PubMed     Text format    


  218. VERMOND RA, Geelhoed B, Rienstra M
    Reply: Antihypertensive Drug Usage in Prediction of Incident Atrial Fibrillation: A Factor Not To Be Disregarded.
    J Am Coll Cardiol. 2016;67:1754-5.
    PubMed     Text format    


  219. ONAT A, Simsek B, Akbas T
    Antihypertensive Drug Usage in Prediction of Incident Atrial Fibrillation: A Factor Not to Be Disregarded.
    J Am Coll Cardiol. 2016;67:1753-4.
    PubMed     Text format    


  220. ANGUERA I, Garcia-Alberola A, Dallaglio P, Toquero J, et al
    Shock Reduction With Long-Term Quinidine in Patients With Brugada Syndrome and Malignant Ventricular Arrhythmia Episodes.
    J Am Coll Cardiol. 2016;67:1653-4.
    PubMed     Text format    


    March 2016
  221. WILDE AA, Postema PG
    Risk Stratification in Brugada Syndrome: The "Impossible" Made Possible?
    J Am Coll Cardiol. 2016;67:1441-3.
    PubMed     Text format    


  222. CALO L, Giustetto C, Martino A, Sciarra L, et al
    A New Electrocardiographic Marker of Sudden Death in Brugada Syndrome: The S-Wave in Lead I.
    J Am Coll Cardiol. 2016;67:1427-40.
    PubMed     Text format     Abstract available


  223. CHEN LY, Agarwal SK, Norby FL, Gottesman RF, et al
    Persistent but not Paroxysmal Atrial Fibrillation Is Independently Associated With Lower Cognitive Function: ARIC Study.
    J Am Coll Cardiol. 2016;67:1379-80.
    PubMed     Text format    


  224. ELLIOTT AD, Pathak RK, Mahajan R, Lau DH, et al
    Reply: Benefit of Exercise in Atrial Fibrillation: Diastolic Function Matters!
    J Am Coll Cardiol. 2016;67:1258-9.
    PubMed     Text format    


  225. HALLE M, Adams V, Edelmann F, Pieske B, et al
    Benefit of Exercise in Atrial Fibrillation: Diastolic Function Matters!
    J Am Coll Cardiol. 2016;67:1257-8.
    PubMed     Text format    


  226. ARBELO E, Sarquella-Brugada G, Brugada J
    Gene-Specific Therapy for Congenital Long QT Syndrome: Are We There Yet?
    J Am Coll Cardiol. 2016;67:1059-61.
    PubMed     Text format    


  227. MAZZANTI A, Maragna R, Faragli A, Monteforte N, et al
    Gene-Specific Therapy With Mexiletine Reduces Arrhythmic Events in Patients With Long QT Syndrome Type 3.
    J Am Coll Cardiol. 2016;67:1053-8.
    PubMed     Text format     Abstract available


  228. POOLE JE, Singh JP, Birgersdotter-Green U
    QRS Duration or QRS Morphology: What Really Matters in Cardiac Resynchronization Therapy?
    J Am Coll Cardiol. 2016;67:1104-17.
    PubMed     Text format     Abstract available


    February 2016
  229. D'AVILA A, Singh SM
    Ventricular Tachycardia Ablation: Are We Winning the Battle But Losing the War?
    J Am Coll Cardiol. 2016;67:684-6.
    PubMed     Text format    


  230. MARCHLINSKI FE, Haffajee CI, Beshai JF, Dickfeld TM, et al
    Long-Term Success of Irrigated Radiofrequency Catheter Ablation of Sustained Ventricular Tachycardia: Post-Approval THERMOCOOL VT Trial.
    J Am Coll Cardiol. 2016;67:674-83.
    PubMed     Text format     Abstract available


  231. MERCHANT FM, Quest T, Leon AR, El-Chami MF, et al
    Implantable Cardioverter-Defibrillators at End of Battery Life: Opportunities for Risk (Re)-Stratification in ICD Recipients.
    J Am Coll Cardiol. 2016;67:435-44.
    PubMed     Text format     Abstract available


  232. LEWIS GF, Gold MR
    Safety and Efficacy of the Subcutaneous Implantable Defibrillator.
    J Am Coll Cardiol. 2016;67:445-54.
    PubMed     Text format     Abstract available


    January 2016
  233. KRACHLER B, Lindahl B
    Atrial Fibrillation Is an Obesity-Related Outcome, Requiring a Body Composition-Neutral Assessment of Cardiorespiratory Fitness.
    J Am Coll Cardiol. 2016;67:349.
    PubMed     Text format    


  234. PATHAK RK, Elliott AD, Mahajan R, Lau DH, et al
    Reply: Atrial Fibrillation Is an Obesity-Related Outcome, Requiring a Body Composition-Neutral Assessment of Cardiorespiratory Fitness.
    J Am Coll Cardiol. 2016;67:349-50.
    PubMed     Text format    


  235. GARDIN JM
    The Value of Left Ventricular Relative Wall Thickness in Predicting Ventricular Arrhythmia and Related Death.
    J Am Coll Cardiol. 2016;67:313-5.
    PubMed     Text format    


  236. BITON Y, Goldenberg I, Kutyifa V, Baman JR, et al
    Relative Wall Thickness and the Risk for Ventricular Tachyarrhythmias in Patients With Left Ventricular Dysfunction.
    J Am Coll Cardiol. 2016;67:303-12.
    PubMed     Text format     Abstract available


  237. BLOOMGARDEN Z, Bansilal S
    A Diabetes-Atrial Fibrillation Conundrum: Does Duration Trump Glycemia?
    J Am Coll Cardiol. 2016;67:248-50.
    PubMed     Text format    


  238. PHILIPPART R, Brunet-Bernard A, Clementy N, Bourguignon T, et al
    CHA2DS2-VASc Score for Predicting Stroke and Thromboembolism in Patients With AF and Biological Valve Prosthesis.
    J Am Coll Cardiol. 2016;67:343-4.
    PubMed     Text format    


  239. ASHBURNER JM, Go AS, Chang Y, Fang MC, et al
    Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients: ATRIA Study.
    J Am Coll Cardiol. 2016;67:239-47.
    PubMed     Text format     Abstract available


  240. HAVAKUK O, Viskin S
    A Tale of 2 Diseases: The History of Long-QT Syndrome and Brugada Syndrome.
    J Am Coll Cardiol. 2016;67:100-8.
    PubMed     Text format     Abstract available


  241. MASOUDI FA, Calkins H, Kavinsky CJ, Drozda JP Jr, et al
    Reply: Left Atrial Appendage Occlusion Device Societal Overview: The Surgeon's Comment.
    J Am Coll Cardiol. 2016;67:125.
    PubMed     Text format    


  242. EMMERT MY, Salzberg SP
    Left Atrial Appendage Occlusion Device Societal Overview: The Surgeon's Comment.
    J Am Coll Cardiol. 2016;67:124.
    PubMed     Text format    


    December 2015
  243. MILLER JD, Aronis KN, Chrispin J, Patil KD, et al
    Obesity, Exercise, Obstructive Sleep Apnea, and Modifiable Atherosclerotic Cardiovascular Disease Risk Factors in Atrial Fibrillation.
    J Am Coll Cardiol. 2015;66:2899-906.
    PubMed     Text format     Abstract available


  244. LIAO Z, Zhan X, Wu S, Xue Y, et al
    Idiopathic Ventricular Arrhythmias Originating From the Pulmonary Sinus Cusp: Prevalence, Electrocardiographic/Electrophysiological Characteristics, and Catheter Ablation.
    J Am Coll Cardiol. 2015;66:2633-2644.
    PubMed     Text format     Abstract available


  245. SHERWOOD MW, Nessel CC, Hellkamp AS, Mahaffey KW, et al
    Gastrointestinal Bleeding in Patients With Atrial Fibrillation Treated With Rivaroxaban or Warfarin: ROCKET AF Trial.
    J Am Coll Cardiol. 2015;66:2271-81.
    PubMed     Text format     Abstract available


  246. LIP GY, Lane DA
    Matching the NOAC to the Patient: Remember the Modifiable Bleeding Risk Factors.
    J Am Coll Cardiol. 2015;66:2282-4.
    PubMed     Text format    


    November 2015
  247. PATHAK RK, Mahajan R, Lau DH, Sanders P, et al
    Reply: BMI Reduction Decreases AF Recurrence Rate in a Mediterranean Cohort.
    J Am Coll Cardiol. 2015;66:2265-6.
    PubMed     Text format    


  248. FIORAVANTI F, Brisinda D, Sorbo AR, Fenici R, et al
    BMI Reduction Decreases AF Recurrence Rate in a Mediterranean Cohort.
    J Am Coll Cardiol. 2015;66:2264-5.
    PubMed     Text format    


  249. VISKIN S, Havakuk O, Schwaber MJ
    Pro-Arrhythmic Effects of Noncardiac Medications: Lessons From Macrolide Antibiotics.
    J Am Coll Cardiol. 2015;66:2185-8.
    PubMed     Text format    


  250. CHENG YJ, Nie XY, Chen XM, Lin XX, et al
    The Role of Macrolide Antibiotics in Increasing Cardiovascular Risk.
    J Am Coll Cardiol. 2015;66:2173-84.
    PubMed     Text format     Abstract available


  251. CAMPUZANO O, Brugada R
    Age, Genetics, and Fibrosis in the Brugada Syndrome.
    J Am Coll Cardiol. 2015;66:1987-9.
    PubMed     Text format    


  252. NADEMANEE K, Raju H, de Noronha SV, Papadakis M, et al
    Fibrosis, Connexin-43, and Conduction Abnormalities in the Brugada Syndrome.
    J Am Coll Cardiol. 2015;66:1976-86.
    PubMed     Text format     Abstract available


    October 2015
  253. PATHAK RK, Mehta AB, Lau DH, Sanders P, et al
    Reply: Going Over LEGACY With a Pinch of Salt.
    J Am Coll Cardiol. 2015;66:1946.
    PubMed     Text format    


  254. VALENTOVA M, Raad N, Anker SD
    Going Over LEGACY With a Pinch of Salt.
    J Am Coll Cardiol. 2015;66:1945.
    PubMed     Text format    


  255. ABRAMOWITZ Y, Jilaihawi H, Chakravarty T, Mack MJ, et al
    Mitral Annulus Calcification.
    J Am Coll Cardiol. 2015;66:1934-41.
    PubMed     Text format     Abstract available


  256. ZIPES DP, Link MS, Ackerman MJ, Kovacs RJ, et al
    Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 9: Arrhythmias and Conduction Defects: A Scientific Statement From the American Heart Association and American College of Cardiolog
    J Am Coll Cardiol. 2015 Oct 27. pii: S0735-1097(15)06577.
    PubMed     Text format    


  257. LINK MS, Estes NA 3rd, Maron BJ
    Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 13: Commotio Cordis: A Scientific Statement From the American Heart Association and American College of Cardiology.
    J Am Coll Cardiol. 2015 Oct 27. pii: S0735-1097(15)06582.
    PubMed     Text format    


  258. GOPINATHANNAIR R, Etheridge SP, Marchlinski FE, Spinale FG, et al
    Arrhythmia-Induced Cardiomyopathies: Mechanisms, Recognition, and Management.
    J Am Coll Cardiol. 2015;66:1714-28.
    PubMed     Text format     Abstract available


    September 2015
  259. DUKKIPATI SR, Cuoco F, Kutinsky I, Aryana A, et al
    Pulmonary Vein Isolation Using the Visually Guided Laser Balloon: A Prospective, Multicenter, and Randomized Comparison to Standard Radiofrequency Ablation.
    J Am Coll Cardiol. 2015;66:1350-60.
    PubMed     Text format     Abstract available


  260. MILLER MA, Neuzil P, Dukkipati SR, Reddy VY, et al
    Leadless Cardiac Pacemakers: Back to the Future.
    J Am Coll Cardiol. 2015;66:1179-89.
    PubMed     Text format     Abstract available


  261. NELSON BW, Van Wagoner DR
    How Does Diazoxide Elicit Arrhythmias in Rats With Type 2 Diabetes?: Is This Effect Clinically Significant?
    J Am Coll Cardiol. 2015;66:1157-9.
    PubMed     Text format    


  262. XIE C, Hu J, Motloch LJ, Karam BS, et al
    The Classically Cardioprotective Agent Diazoxide Elicits Arrhythmias in Type 2 Diabetes Mellitus.
    J Am Coll Cardiol. 2015;66:1144-56.
    PubMed     Text format     Abstract available


  263. KOWEY PR, Robinson VM
    Observing the Obvious.
    J Am Coll Cardiol. 2015;66:1008-10.
    PubMed     Text format    


    June 2015
  264. MASOUDI FA, Calkins H, Kavinsky CJ, Drozda JP Jr, et al
    2015 ACC/HRS/SCAI Left Atrial Appendage Occlusion Device Societal Overview: A Professional Societal Overview from the American College of Cardiology, Heart Rhythm Society, and Society for Cardiovascular Angiography and Interventions.
    J Am Coll Cardiol. 2015 Jun 20. pii: S0735-1097(15)02852.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: